“No one is looking at this as a moneymaking commercial business. It’s just how quickly can we help.”

Question: When leronlimab is approved by FDA for covid, there will likely be enormous pressure to lower the price (currently $1-2K per dose?) significantly. If this happens (via grants for mass production or something else), how would this effect the long term financial picture for a one-hit-wonder-drug company like CYDY when the original per-dose price was used to evaluate future profits?